QUESTRAN (Par Pharmaceutical, Inc.)


Welcome to the PulseAid listing for the QUESTRAN drug offered from Par Pharmaceutical, Inc.. This Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Par Pharmaceutical, Inc.
NON-PROPRIETARY NAME: Cholestyramine
SUBSTANCE NAME: CHOLESTYRAMINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA]
ROUTE: ORAL
DOSAGE FORM: POWDER, FOR SUSPENSION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2005-09-15
END MARKETING DATE: 0000-00-00


QUESTRAN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionQUESTRAN from Par Pharmaceutical, Inc.
LABELER NAME: Par Pharmaceutical, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 4(g/9g)
START MARKETING DATE: 2005-09-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49884-936_cbafb444-c4f5-4230-8d90-b023aaca26ea
PRODUCT NDC: 49884-936
APPLICATION NUMBER: ANDA077204

Other CHOLESTYRAMINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cadila Healthcare LimitedCHOLESTYRAMINE
Eon Labs, Inc.cholestyramine light
Par Pharmaceutical, Inc.Cholestyramine
Physicians Total Care, Inc.Cholestyramine
Upsher-Smith Laboratories, Inc.Cholestyramine
Upsher-Smith Laboratories, LLCPrevalite
Zydus Pharmaceuticals (USA) Inc.CHOLESTYRAMINE